Mcgee, CA
Bobby Mcgee, Rancho Cucamonga, CA US
Patent application number | Description | Published |
---|---|---|
20140027486 | Concealment Holster - A concealment holster that is designed to be concealed under a jacket or shirt, or even under the waistband of a pair of trousers includes two clips that support it on the wearer's belt. A foam and mesh backing provides comfort to the wearer. | 01-30-2014 |
20140034691 | Holder for Shotgun Speedloaders - A holder for speedloader tubes includes a plate that can be secured to a portion of a user's body; a plurality of upwardly opening pockets on the plate; and a plurality of clips on the plate. Each one of the clips is located above and is associated with a respective one of the pockets. The lower end of the tube is received in the pocket and an upper portion of the tube is retained in the associated clip. | 02-06-2014 |
Brian Mcgee, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20150052401 | SYSTEMS AND METHODS FOR INVASIVE DEBUG OF A PROCESSOR WITHOUT PROCESSOR EXECUTION OF INSTRUCTIONS - Methods for invasive debug of a processor without processor execution of instructions are disclosed. As a part of a method, a memory mapped I/O of the processor is accessed using a debug bus and an operation is initiated that causes a debug port to gain access to registers of the processor using the memory mapped I/O. The invasive debug of the processor is executed from the debug port via registers of the processor. | 02-19-2015 |
Brian J. Mcgee, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20100241814 | BANDWIDTH-EFFICIENT DIRECTORY-BASED COHERENCE PROTOCOL - Some embodiments of the present invention provide a system that processes a request for a cache line in a multiprocessor system that supports a directory-based cache-coherence scheme. During operation, the system receives the request for the cache line from a requesting node at a home node, wherein the home node maintains directory information for all or a subset of the address space which includes the cache line. Next, the system performs an action at the home node, which causes a valid copy of the cache line to be sent to the requesting node. The system then completes processing of the request at the home node without waiting for an acknowledgment indicating that the requesting node received the valid copy of the cache line. | 09-23-2010 |
20140310555 | PHYSICAL DOMAIN ERROR ISOLATION AND RECOVERY IN A MULTI-DOMAIN SYSTEM - The disclosed embodiments disclose techniques for performing physical domain error isolation and recovery in a multi-domain system, where the multi-domain system includes two or more processor chips and one or more switch chips that provide connectivity and cache-coherency support for the processor chips, and the processor chips are divided into two or more distinct domains. During operation, one of the switch chips determines a fault in the multi-domain system. The switch chip determines an originating domain that is associated with the fault, and then signals the fault and an identifier for the originating domain to its internal units, some of which perform clearing operations that clear out all traffic for the originating domain without affecting the other domains of the multi-domain system. | 10-16-2014 |
Danny P.c. Mcgee, Vista, CA US
Patent application number | Description | Published |
---|---|---|
20090175888 | METHODS OF TREATING CANCER WITH AN ANTIBODY-DRUG CONJUGATE - The present invention provides analogues of duocarmycins that are potent cytotoxins. Also provided are peptidyl and disulfide linkers that are cleaved in vivo. The linkers are of use in forming prodrugs and conjugates of the cytotoxins of the invention as well as other diagnostic and therapeutic moieties. The invention provides prodrugs and conjugates of the duocarmycin analogues with the linker arms of the invention. | 07-09-2009 |
20090209734 | PEPTIDYL PRODRUGS AND LINKERS AND STABILIZERS USEFUL THEREFOR - The present invention provides analogues of duocarmycins that are potent cytotoxins. Also provided are peptidyl and disulfide linkers that are cleaved in vivo. The linkers are of use in forming prodrugs and conjugates of the cytotoxins of the invention as well as other diagnostic and therapeutic moieties. The invention provides prodrugs and conjugates of the duocarmycin analogues with the linker arms of the invention. | 08-20-2009 |
Danny Peter Claude Mcgee, Vista, CA US
Patent application number | Description | Published |
---|---|---|
20080207635 | Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders - The present invention provides compounds capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use. | 08-28-2008 |
David Mcgee, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20110040167 | SYSTEMS AND METHODS FOR MAKING AND USING MEDICAL ABLATION SYSTEMS AND HAVING MAPPING CATHETERS WITH IMPROVED ANCHORING ABILITY - A mapping catheter includes an elongated body for inserting into patient vasculature. A distal end of the elongated body includes a distal portion that includes a plurality of electrodes, a proximal portion disposed proximal to the distal portion, and a reduced-dimension portion disposed between the proximal and distal portions. The distal end is formed, at least in part, from a memory shape material that bends into a preformed shape upon release from a confined space. The preformed shape includes a first loop formed, at least in part, by the distal portion. The first loop is transverse to a longitudinal axis of the proximal portion. The reduced-dimension portion is configured and arranged to bend such that the reduced-dimension section advances distally through the first loop when the first loop is held in a fixed position and a force is applied distally along the longitudinal axis of the proximal portion. | 02-17-2011 |
20120245469 | FAR-FIELD AND NEAR-FIELD ULTRASOUND IMAGING DEVICE - Devices, systems, and methods for ultrasonically acquiring far-field and near-field images within a body are disclosed. An ultrasound imaging device adapted for insertion within a body includes a first ultrasonic sensor configured to transmit ultrasonic waves at a first frequency for acquiring far-field images within the body, and a second ultrasonic sensor configured to transmit ultrasonic waves at a higher frequency than the first frequency for acquiring near-field images within the body. The ultrasound imaging device can be connected to a control device and user interface for visualizing far-field and near-field images acquired by the ultrasonic sensors. | 09-27-2012 |
20130165759 | SYSTEMS AND METHODS FOR MAKING AND USING MEDICAL ABLATION SYSTEMS HAVING MAPPING CATHETERS WITH IMPROVED ANCHORING ABILITY - A mapping catheter includes an elongated body for inserting into patient vasculature. A distal end of the elongated body includes a distal portion that includes a plurality of electrodes, a proximal portion disposed proximal to the distal portion, and a reduced-dimension portion disposed between the proximal and distal portions. The distal end is formed, at least in part, from a memory shape material that bends into a preformed shape upon release from a confined space. The preformed shape includes a first loop formed, at least in part, by the distal portion. The first loop is transverse to a longitudinal axis of the proximal portion. The reduced-dimension portion is configured and arranged to bend such that the reduced-dimension section advances distally through the first loop when the first loop is held in a fixed position and a force is applied distally along the longitudinal axis of the proximal portion. | 06-27-2013 |
David Mcgee, San Miguel, CA US
Patent application number | Description | Published |
---|---|---|
20140257261 | SYSTEMS AND METHODS FOR MAKING AND USING MEDICAL ABLATION SYSTEMS HAVING MAPPING CATHETERS WITH IMPROVED ANCHORING ABILITY - A mapping catheter includes an elongated body for inserting into patient vasculature. A distal end of the elongated body includes a distal portion that includes a plurality of electrodes, a proximal portion disposed proximal to the distal portion, and a reduced-dimension portion disposed between the proximal and distal portions. The distal end is formed, at least in part, from a memory shape material that bends into a preformed shape upon release from a confined space. The preformed shape includes a first loop formed, at least in part, by the distal portion. The first loop is transverse to a longitudinal axis of the proximal portion. The reduced-dimension portion is configured and arranged to bend such that the reduced-dimension section advances distally through the first loop when the first loop is held in a fixed position and a force is applied distally along the longitudinal axis of the proximal portion. | 09-11-2014 |
David L. Mcgee, San Miguel, CA US
Patent application number | Description | Published |
---|---|---|
20140081262 | NEARFIELD ULTRASOUND ECHOGRAPHY MAPPING - Various embodiments concern delivering an ablation therapy to different areas of the cardiac tissue and, for each of the areas, sensing an ultrasound signal with at least one ultrasound sensor, the ultrasound signal responsive to the ultrasound energy reflected from the area of cardiac tissue. Such embodiments can further include for each of the plurality of different areas of the cardiac tissue, associating with each area an indication of the degree to which the area of cardiac tissue was lesioned by the delivery of the ablation therapy based on the ultrasound signal and representing a map of the different areas on a display. A user input can select one of the different areas and the indication associated with the selected one area can be represented on the map. | 03-20-2014 |
20140336477 | FAR-FIELD AND NEAR-FIELD ULTRASOUND IMAGING DEVICE - Devices, systems, and methods for ultrasonically acquiring far-field and near-field images within a body are disclosed. An ultrasound imaging device adapted for insertion within a body includes a first ultrasonic sensor configured to transmit ultrasonic waves at a first frequency for acquiring far-field images within the body, and a second ultrasonic sensor configured to transmit ultrasonic waves at a higher frequency than the first frequency for acquiring near-field images within the body. The ultrasound imaging device can be connected to a control device and user interface for visualizing far-field and near-field images acquired by the ultrasonic sensors. | 11-13-2014 |
David L. Mcgee, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20120310064 | ABLATION PROBE WITH ULTRASONIC IMAGING CAPABILITIES - Devices and systems for ultrasonically imaging anatomical structures and performing ablation therapy within the body are disclosed. A combined ablation and ultrasound imaging probe includes a housing, an ablation electrode located on a distal tip section of the housing, and a number of ultrasonic imaging sensors configured for visualizing anatomical structures within the body. During an ablation procedure, the ultrasonic imaging sensors can be tasked to generate a number of ultrasonic images that can be displayed as a composite image on a display screen of a user interface. | 12-06-2012 |
20140051993 | AUTOMATED ACTIVATION/DEACTIVATION OF IMAGING DEVICE BASED ON TRACKED MEDICAL DEVICE POSITION - Methods and systems for controlling an imaging procedure are provided. A medical device is introduced within a patient, and a position (e.g., location and/or orientation) of the medical device is detected within the patient relative to a reference position (e.g., a previously detected position of the medical device or a position within a desired path). Imaging of the patient is automatically activated based on the detected relative position, such that the patient is imaged only during relevant times. In one method, instability/stability of the medical device is detected, in which case, the imaging is automatically activated when the medical device is unstable, and deactivated when the medical device is stable. For example, if tissue is to be ablated with the medical device, medical personnel can be made aware of inadvertent movement of the medical device via the image, and can correct any displacement of the medical device from the ablation site. | 02-20-2014 |
Evan Patrick Mcgee, Santa Monica, CA US
Patent application number | Description | Published |
---|---|---|
20140269678 | METHOD FOR PROVIDING AN APPLICATION SERVICE, INCLUDING A MANAGED TRANSLATION SERVICE - The present invention provides a method for providing an application service, such as a managed translation service. In an embodiment, a voice call is established between a source station and a destination station. A decision may be made as to whether language translation is desired, such as from an indicator specifying commencement of a translation session. If the translation service is commenced, then the call is directed to a gateway for transmission over a data network to a translation application, which may be a cloud-based application. The translation may occur in real time or near real time. Translated speech may be displayed to the calling party and/or the called party. | 09-18-2014 |
Georgina J. Mcgee, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20140331675 | PIVOTING SWIRLER INLET VALVE PLATE - A swirler inlet valve plate for a fuel injector of a gas turbine engine includes a blocker ring and a pivot sleeve mechanically connected to the blocker ring. The blocker ring is formed from at least a portion of a toroid shape. The blocker ring includes a blocking surface perpendicular to an axis of the blocker ring formed from at least a portion of an annulus. The blocker ring also includes a flow surface, an inner circumferential surface of the toroidal shape. The pivot sleeve includes a sleeve portion extending adjacent the blocker ring. The sleeve portion includes a rotation transmission mechanism. | 11-13-2014 |
Ian J. Mcgee, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20100036736 | SYSTEM AND METHOD FOR REVENUE SHARING WITH A FITNESS CENTER - Systems and methods for revenue sharing with a fitness center are disclosed. In one aspect, embodiments of the present disclosure include a method, which may be implemented on a system, to incentivize purchase of internet and/or web-enabled exercise equipment by a fitness center. One embodiment can include, assessing a fee from a user of the internet and/or web-enabled exercise equipment, collecting at least a portion of the fee from the user, and sharing the at least a portion of the fee with the fitness center where the internet and/or web-enabled exercise equipment is physically located. | 02-11-2010 |
Jeffrey Dykes Mcgee, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110095187 | APPARATUS AND METHODS FOR USE IN FLASH DETECTION - The present embodiments provide methods, systems and apparatuses that detect, classify and locate flash events. In some implementations, some of the methods detect a flash event, trigger an imaging system in response to detecting the flash event to capture an image of an area that includes the flash event, and determines a location of the flash event. | 04-28-2011 |
20120001071 | APPARATUS AND METHODS FOR USE IN FLASH DETECTION - The present embodiments provide methods, systems and apparatuses that detect, classify and locate flash events. In some implementations, some of the methods detect a flash event, trigger an imaging system in response to detecting the flash event to capture an image of an area that includes the flash event, and determines a location of the flash event. | 01-05-2012 |
20130343602 | APPARATUS AND METHODS FOR USE IN FLASH DETECTION - The present embodiments provide methods, systems and apparatuses that detect, classify and locate flash events. In some implementations, some of the methods detect a flash event, trigger an imaging system in response to detecting the flash event to capture an image of an area that includes the flash event, and determines a location of the flash event. | 12-26-2013 |
Lawrence Mcgee, Pacifica, CA US
Patent application number | Description | Published |
---|---|---|
20110319378 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER - The present invention provides MDM2 inhibitor compounds of Formula I, | 12-29-2011 |
Lawrence R. Mcgee, Pacifica, CA US
Patent application number | Description | Published |
---|---|---|
20090137581 | Heterocyclic compounds and their uses - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 05-28-2009 |
20090221584 | Bisaryl-sulfonamides - Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPARγ or PPARδ. In particular, the compounds of the invention modulate the function of PPARγ or PPARδ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis. | 09-03-2009 |
20090221635 | QUINOLINYL AND BENZOTHIAZOLYL MODULATORS - Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPARγ. In particular, the compounds of the invention modulate the function of PPARγ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis. | 09-03-2009 |
20110086834 | ALKYNYL ALCOHOLS AS KINASE INHIBITORS - Selected compounds are effective for prophylaxis and treatment of inflammation and inflammatory disorders, such as NIK-mediated disorders. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, inflammation and the like. | 04-14-2011 |
20110097305 | Gem-Disubstituted and Spirocyclic Amino Pyridines/Pyrimidines as Cell Cycle Inhibitors - Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4-me-dialed disorders, such as cancer. The subject compounds arc gem-disubstituted or spimcyclic pyridine, pyrimidine and triazine derivatives. | 04-28-2011 |
20110142796 | Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibitors - Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4-mediated disorders, such as cancer. The subject compounds are fused pyridine, pyrimide and triazine derivatives. | 06-16-2011 |
20120220585 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 08-30-2012 |
20120220586 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 08-30-2012 |
20120244110 | FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3 - Compounds of Formula I are useful inhibitors of CDK 4, CDK6, and FLT3. Such compounds are useful in treating cancer and various other disease conditions. Compounds of Formula I have the following structure: | 09-27-2012 |
20140163052 | FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3 - Compounds of Formula I are useful inhibitors of CDK 4, CDK6, and FLT3. Such compounds are useful in treating cancer and various other disease conditions. Compounds of Formula I have the following structure: | 06-12-2014 |
20140199728 | METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROPERTIES OF A CELL CULTURE - Methods of modulating the properties of a cell culture expressing a protein of interest are provided. In various embodiments the methods relate to the addition of cell cycle inhibitors to growing cell cultures. | 07-17-2014 |
20140315895 | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER - The present invention provides MDM2 inhibitor compounds of Formula I, | 10-23-2014 |
20140350244 | FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INHIBITORS - Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4-mediated disorders, such as cancer. The subject compounds are fused pyridine, pyrimide and triazine derivatives. | 11-27-2014 |
20140364455 | PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR - The present invention provides processes for making 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid as well as intermediates and processes for making the intermediates. Also provided are crystalline forms of the compound and the intermediates. | 12-11-2014 |
20150045361 | HETEROCYCLIC COMPOUNDS AND THEIR USES - Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer. | 02-12-2015 |
Lawrence R. Mcgee, Pacific, CA US
Patent application number | Description | Published |
---|---|---|
20100113522 | COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY - Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity. | 05-06-2010 |
Lawrence R. Mcgee, Pacificia, CA US
Patent application number | Description | Published |
---|---|---|
20090149648 | NUCLEOTIDE ANALOGS - Nucleotide analogs characterized by the presence of an amidate linked amino acid or an ester linked group which is bonded to the phosphorus atom of phosphonate nucleotide analogs are disclosed. The analogs comprise a phosphoamidate or ester bond that is hydrolyzed in vivo to yield a corresponding phosphonate nucleotide analog. Methods and intermediates for their synthesis and use are described. | 06-11-2009 |
Linda Mcgee, Newark, CA US
Patent application number | Description | Published |
---|---|---|
20110202360 | SUPPLIER ENROLLMENT PROGRAM - Methods and systems are presented for a supplier enrollment program in which suppliers who are not enrolled in a payment processing network such as Visa are aggregated, commercial data about them is obtained and appended to the data, and the resulting sales leads are distributed to acquirers. If the acquirer fails to sign up the supplier within a predetermined time limit, then the sales lead is pulled back from the acquirer and rotated to another acquirer to let the other acquirer attempt to sign up the supplier. | 08-18-2011 |
Melvin Mcgee, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20150205685 | IN-BAND RECOVERY MECHANISM FOR I/O MODULES IN A DATA STORAGE SYSTEM - Technology is disclosed for recovering I/O modules in a storage system using in-band alternate control path (ACP) architecture (“the technology”). The technology enables a storage server to transmit control commands, e.g., for recovering an I/O module, to the I/O module over a data path that is typically used to transmit data commands. The control commands are typically transmitted using ACP that is separate from the data path. By enabling transmission of control commands over the data path, the technology eliminates the need for separate medium for ACP, at least in part, to transmit the control commands. The technology can be implemented in a pure in-band ACP mode, which supports recovering an I/O module of a storage shelf in which at least one I/O module is responsive, and/or in a mixed in-band ACP mode, which supports recovery of I/O modules of a storage shelf in which all I/O modules are non-responsive. | 07-23-2015 |
Michael Dale Mcgee, Oakland, CA US
Patent application number | Description | Published |
---|---|---|
20140165819 | DRUM TUNER - A drum tuner is described. The drum tuner includes: (i) a hub gear; (ii) two or more differential gears communicatively coupled to the hub gear and at least one of the two or more differential gears capable of engaging a tuning mechanism of a drum; and (iii) wherein, during an operational state of the drum tuner, rotation of the hub gear rotates at least one of the two or more differential gears to activate the drum's tuning mechanism. | 06-19-2014 |
Mitchell Mcgee, Santa Rosa, CA US
Patent application number | Description | Published |
---|---|---|
20140093239 | OLT MAC MODULE FOR EFFICIENTLY PROCESSING OAM FRAMES - Embodiments of the present disclosure provide efficient solutions for detecting and transmitting heartbeat frames at an optical line terminal (OLT) of an Ethernet passive optical network (EPON). The processing burden of a host CPU is reduced by shifting some of the processing responsibilities of the host CPU to an embedded CPU. An OAM capture FIFO buffer stores frames for later processing by the embedded CPU, and fields of an OAM vector register are changed whenever a heartbeat frame is detected for an LLID. Embedded CPU polls the OAM vector at a predetermined rate sufficient to maintain link status, so heartbeat messages are not missed even when the OAM capture FIFO buffer overflows. Additionally, an OAM generation buffer efficiently creates new heartbeat messages to be sent to ONUs for each supported LLID by modifying previously transmitted OAM frames with new information specific to the LLIDs. | 04-03-2014 |
Mitchell Gordon Mcgee, Petaluma, CA US
Patent application number | Description | Published |
---|---|---|
20130177313 | Ethernet Passive Optical Network with Report Threshold Calculations - The present disclosure is directed to a method and apparatus for maintaining sub-queues at an ONU and for maintaining a count of an amount of data stored in each sub-queue or a count of an amount of data associated with elements stored in each sub-queue. The sub-queues represent partitions in a first in, first out (FIFO) queue used by the ONU to buffer packets, or elements that are associated with packets, to be sent upstream. The sub-queues are coupled in series such that the output of a first sub-queue feeds the input of a second sub-queue, the output of the second sub-queue feeds the input of a third sub-queue, etc. Each sub-queue has a defined threshold that sets a maximum amount of packet data it can buffer or the elements in which it buffers can be associated with. | 07-11-2013 |
Phillip W. Mcgee, Chino Hills, CA US
Patent application number | Description | Published |
---|---|---|
20080231871 | METHOD FOR VIEWING AND PRINTING DOUBLE-SIDED ITEMS - A method for displaying indicia that is to be printed on a double-sided item on a computer screen. The double-sided item has first and second surfaces. The indicia has at least one print orientation when the indicia is printed on the item's first and second surfaces, and at least one view orientation when the indicia is displayed on the computer screen, which has a vertical orientation. The method includes providing information that characterizes the indicia's print orientation, using the information to compare the print orientation to the vertical orientation; and if, as a result of the comparison, the print orientation does not match the vertical orientation, adjusting the view orientation so the view orientation matches the vertical orientation while maintaining the indicia's print orientation when the indicia is printed on the item. | 09-25-2008 |
20090046324 | SEQUENCING AND REPRODUCING SETS OF TEXT AND GRAPHICS ACROSS A COLLECTION OF PRINTABLE AREAS - A method of sequencing and reproducing sets of text and graphics across a collection of printable areas and a computer readable medium having computer-executable instructions for performing the method. The method providing the user the ability to select many variables for the printing of labels for tabs. The method and computer readable medium providing for the creation of divider insert tab labels for the tabs of a set of divider inserts thereby identifying the divided contents. The method and computer printable medium provide for printing of the divider insert tab labels in an order that they are assembled into a binder. | 02-19-2009 |
20150205545 | METHOD FOR VIEWING AND PRINTING DOUBLE-SIDED ITEMS - A method for displaying indicia that is to be printed on a double-sided item on a computer screen. The double-sided item has first and second surfaces. The indicia has at least one print orientation when the indicia is printed on the item's first and second surfaces, and at least one view orientation when the indicia is displayed on the computer screen, which has a vertical orientation. The method includes providing information that characterizes the indicia's print orientation, using the information to compare the print orientation to the vertical orientation; and if, as a result of the comparison, the print orientation does not match the vertical orientation, adjusting the view orientation so the view orientation matches the vertical orientation while maintaining the indicia's print orientation when the indicia is printed on the item. | 07-23-2015 |
Thomas Edward Mcgee, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20130198301 | System and Method for Conveying Information - A system and method for conveying data include the capability to determine whether a transaction request credit has been received at a computer module, the transaction request credit indicating that at least a portion of a transaction request message may be sent. The system and method also include the capability to determine, of a transaction request message is to be sent, whether at least a portion of the transaction request message may be sent and to send the at least a portion of the transaction request message if it may be sent. | 08-01-2013 |
20140337691 | SYSTEM AND METHOD FOR CONVEYING INFORMATION - A system and method for conveying data include the capability to determine whether a transaction request credit has been received at a computer module, the transaction request credit indicating that at least a portion of a transaction request message may be sent. The system and method also include the capability to determine, of a transaction request message is to be sent, whether at least a portion of the transaction request message may be sent and to send the at least a portion of the transaction request message if it may be sent. | 11-13-2014 |
Thomas F. Mcgee, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080275313 | TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host. | 11-06-2008 |
20100097223 | PRODUCT SECURITY SYSTEM - The present system provides a tag having one or more components comprising a physically rugged structure which can be attached to a product in a manner that renders the product inoperable, defaced, or that otherwise denies access to the intended use or value of the product until it is “unlocked” by means of a wireless communication, such as by a radio frequency transmission. The tag comprises a latching mechanism comprising in part an “actuator” and a “gripper”. | 04-22-2010 |
20100174157 | TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host. | 07-08-2010 |
20100174163 | TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host. | 07-08-2010 |
20100185069 | TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host. | 07-22-2010 |
20120277562 | TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host. | 11-01-2012 |
20140012229 | DRIVE CONTROL MECHANISMS AND AUTOMATIC INJECTORS FOR INJECTABLE CARTRIDGES - An automatic injector includes a housing having a guide, a drive control mechanism, a transmission assembly, a motor, and an energy source. The housing may further include a cartridge cover. A drive control mechanism includes a drive screw, a cartridge carrier, a plunger carrier, and one or more control transfer instruments, such as a puck or cylinder. The drive screw interfaces and connects with the plunger carrier. The automatic injector is configured to accept a variety of syringes as cartridges for drug delivery. The cartridges may be ejected from the injector and safely disposed after use, making the injector a reusable automatic injector. The reusable automatic injector may further include one or more sensors, such as a cartridge sensor and a patient sensor. The novel incorporation of the drive control mechanisms into the automatic injectors of the present invention enables a single motor and transmission assembly to drive the function of multiple components, which may include the steps of: preparation and alignment of a cartridge for injection, removal of a safety cap or needle shield, needle injection, drug dose delivery, and syringe and/or needle retraction. Methods of manufacture and methods of use are also disclosed. | 01-09-2014 |
20150174326 | DRIVE CONTROL MECHANISMS AND AUTOMATIC INJECTORS FOR INJECTABLE CARTRIDGES - An automatic injector includes a housing having a guide, a drive control mechanism, a transmission assembly, a motor, and an energy source. The housing may further include a cartridge cover. A drive control mechanism includes a drive screw, a cartridge carrier, a plunger carrier, and one or more control transfer instruments, such as a puck or cylinder. The drive screw interfaces and connects with the plunger carrier. The automatic injector is configured to accept a variety of syringes as cartridges for drug delivery. The cartridges may be ejected from the injector and safely disposed after use, making the injector a reusable automatic injector. The reusable automatic injector may further include one or more sensors, such as a cartridge sensor and a patient sensor. The novel incorporation of the drive control mechanisms into the automatic injectors of the present invention enables a single motor and transmission assembly to drive the function of multiple components, which may include the steps of: preparation and alignment of a cartridge for injection, removal of a safety cap or needle shield, needle injection, drug dose delivery, and syringe and/or needle retraction. Methods of manufacture and methods of use are also disclosed. | 06-25-2015 |
Tom Mcgee, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110178461 | INSERTION DEVICE SYSTEMS AND METHODS - An insertion device may include a device housing configured to be operatively engaged with and disengaged from a base, and engageable with an actuation device, the device housing having a carrier body supporting a piercing member. The carrier body moveable by a carrier body of the actuation device at least between a retracted position and an advanced position. The device housing having a section for supporting a portion of the carrier body of the device housing, the section moveable relative to the carrier body of the device housing to provide sufficient clearance to allow the carrier body of the device housing to be moved by the carrier body of the actuation device. | 07-21-2011 |
20120029385 | INSERTION DEVICE SYSTEMS AND METHODS - An insertion device may include a base adapted to be carried by a patient, and a housing attached to the base, the housing having a fluid connector arranged for movement relative to the base. A pair of interactive elements including a first interactive element may be supported on the base and a second interactive element supported on the housing at a location to be interactable with the first interactive element when the fluid connector is moved to a predetermined position. Circuitry may be configured to detect an interaction between the first interactive element and the second interactive element when the fluid connector is in the predetermined position, the circuitry configured to provide a signal or a change in state in response to detecting the interaction between the first interactive element and the second interactive element. | 02-02-2012 |
William A. Mcgee, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20100153893 | CONSTRAINT MANAGEMENT AND VALIDATION FOR TEMPLATE-BASED CIRCUIT DESIGN - A technique for constraint management and validation for template-based device designs is disclosed. The technique includes generating a template-level representation of an electronic device design based on a transistor-level representation of the electronic device design. The template-level representation includes one or more hierarchies of templates. Each template represents a corresponding portion of the electronic device design. The technique further includes determining constraint declarations associated with the electronic device design and verifying whether there is a functional equivalence between the template-level representation to a register-transfer-level (RTL) representation of the electronic device design. The technique additionally includes verifying whether the constraint declarations are valid and verifying the electronic device design responsive to verifying the functional equivalence and verifying the constraint declarations. | 06-17-2010 |
20120167030 | METHOD AND APPARATUS FOR ADDRESSING AND IMPROVING HOLDS IN LOGIC NETWORKS - A method and apparatus for modifying a synchronous logic network so that the hold slack calculated at all pins is greater than or equal to a user-specified threshold, with the condition that the setup slack at any pin does not become negative or smaller than a user-specified margin. The result is an improved design which is less likely to fail due to a hold time violation. The method and apparatus introduce a limited number of logic cells which helps keep power consumption and design size to a minimum. | 06-28-2012 |